Similar Papers

Paper Title
Journal
Date
Author
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
Bram De Laere ... Johan Lindberg
Nature Medicine | VOL. 30
Bram De Laere, et. al.Bram De Laere ... Johan Lindberg
20 Aug 2024
Abstract A31: High aneuploidy levels are linked to a reduced immune-cell abundance in metastatic castrate-resistant prostate cancer
Thiago Vidotto ... Tamara L Lotan
Cancer Immunology Research | VOL. 8
Thiago Vidotto, et. al.Thiago Vidotto ... Tamara L Lotan
01 Mar 2020
Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.
Krzysztof Adamowicz
Quality of Life Research | VOL. 26
Krzysztof AdamowiczKrzysztof Adamowicz
13 Oct 2016
Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials
Michael J Grayling ... Martina Mcmenamin
BMC Cancer | VOL. 22
Michael J Grayling, et. al.Michael J Grayling ... Martina Mcmenamin
26 Jan 2022
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial
Marcela Carausu ... Michail Ignatiadis
Annals of Oncology | VOL. 36
Marcela Carausu, et. al.Marcela Carausu ... Michail Ignatiadis
01 Feb 2025
Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors
J.M Riedl ... R.B Corcoran
Annals of Oncology | VOL. -
J.M Riedl, et. al.J.M Riedl ... R.B Corcoran
01 Feb 2025
Whole genome sequencing powered ctDNA sequencing for breast cancer detection
I Garcia-Murillas ... N.C Turner
Annals of Oncology | VOL. -
I Garcia-Murillas, et. al.I Garcia-Murillas ... N.C Turner
01 Feb 2025
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.